Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2005
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050260597 Transfection reagents
11/24/2005CA2565953A1 Piperidine derivatives as nk1 and nk3 antagonists
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/23/2005EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1597231A1 Derivatives of azasugars as anticancer agents
11/23/2005EP1597228A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments
11/23/2005EP0934263B1 Non-immunosuppressant fkbp rotamase inhibitors
11/23/2005CN1699545A Apparatus and method for controlling biofilms
11/23/2005CN1699349A Method and reagents for N-alkylating ureides
11/23/2005CN1699345A Method of preparing 4 bit substituted 2,2,6,6-four cymene piperidine-N-oxygen and 2,2,6,6-four cymene piperidine-N- hydroxyl compound
11/23/2005CN1699344A Sulfur-containing structural compounds and their preparation process and use
11/23/2005CN1699343A Polymorphs of donepezil hydrochloride and process for production
11/23/2005CN1228326C Method for producing N-alkenyl amides
11/22/2005US6967252 Comprising a sterically hindered nitroxyl, hydroxylamine or hydrocarbyloxyamine moiety and a organohalogen or organophosphorus flame retardant moiety; polymer molding substrates; synergistic; nondripping; air pollution control
11/22/2005US6967208 Anticoagulants; cardiovascular disorders
11/22/2005US6967199 Substituted diamine derivatives useful as motilin antagonists
11/22/2005CA2257094C Sterically hindered 4-amino-piperidine with a low dimer content, its production and use
11/22/2005CA2252806C Polymorphs of donepezil hydrochloride and process for production
11/22/2005CA2162122C Use of glycine-n,n-diacetic acid derivatives as biodegradable complexing agents for alkaline earth and heavy metal ions, and method of preparing them
11/17/2005WO2005108391A1 Amides as bace inhibitors
11/17/2005WO2005108381A1 Synthesis and uses of synephrine derivatives
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005108361A1 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/17/2005WO2005108360A1 Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/17/2005WO2005108359A1 Novel compounds of proline and morpholine derivatives
11/17/2005WO2005108358A2 Pyrrolidine derivatives useful as bace inhibitors
11/17/2005WO2005108351A1 Benzonitrile derivatives to treat musculoskeletal frailty
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005WO2005107464A2 Compounds and compositions as cathepsin s inhibitors
11/17/2005WO2005107374A2 A process for the preparation of 1,4-dihydropyridine-3,5-dicarboxylic acid derivative
11/17/2005WO2005030751A3 Dipeptidyl peptidase inhibitors
11/17/2005WO2005016264A3 Diamine derivatives of quinone and uses thereof
11/17/2005US20050256312 Process for preparing 4-substituted 2,2,6,6-tetramethylpiperidin-N-oxy and 2,2,6,6-tetramethylpiperidin-N-hydroxy compounds
11/17/2005US20050256308 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
11/17/2005US20050256164 NK1 and NK3 antagonists
11/17/2005US20050256163 Crystalline forms of fexofenadine hydrochloride and processes for their preparation
11/17/2005US20050256162 Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
11/17/2005US20050256159 1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors
11/17/2005US20050256137 Pyridone compounds as inhibitors of bacterial type III protien secreation systems
11/17/2005US20050256133 Thio-substituted arylmethanesulfinyl derivatives
11/17/2005US20050256132 Use of ER selective NF-kB inhibitors for the treatment of sepsis
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/17/2005US20050256089 for use as pesticides, herbicides; condensation
11/17/2005US20050256078 Hepatitis C; toxicity, side effects reduction; improved pharmacological/pharmacokinetics properties; novel intermediates; increased cellular accumulation and retention of a drug compound, to improve their therapeutic and diagnostic value, comprising linking the compound to one or more phosphonate groups
11/17/2005DE102004019472A1 Phenylacetamide Phenylacetamides
11/17/2005CA2565843A1 Novel compounds of proline and morpholine derivatives
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/17/2005CA2565632A1 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/17/2005CA2565630A1 Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/17/2005CA2565544A1 Benzonitrile derivatives to treat musculoskeletal frailty
11/16/2005EP1595868A1 Process for the preparation of 4-substituted 2,2,6,6-tetramethyl-N-oxy and 2,2,6,6-tetramethyl-N-hydroxy piperidines
11/16/2005EP1595867A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
11/16/2005EP1594867A2 Phenylacetamides and their use as glucokinase modulators
11/16/2005EP1594860A2 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/16/2005EP1594859A1 Indazolamides with analgesic activity
11/16/2005EP1594846A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
11/16/2005EP1594840A1 Piperidine-benzenesulfonamide derivatives
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1330464B1 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
11/16/2005EP1147085B1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors / tnf-alpha converting enzyme (tace) inhibitors
11/16/2005CN1696115A Synthesized building block of derivative of 4-substituent-4-amido-piperidine, preparation method and application
11/16/2005CN1227230C Prodrugs to NMDA receptor lagans
11/16/2005CN1227226C Preparation of Lactams from aliphatic alpha, omega-dinitriles
11/15/2005US6965048 Hydroxyalkylamide derivatives
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964974 2,3-oxidosqualene-lanosterol cyclase inhibitors
11/15/2005CA2433190C Amlodipine hemimaleate
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/15/2005CA2330351C New linear or cyclical ureas, their preparation process and the pharmaceutical compositions which contain them
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005105766A2 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105743A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
11/10/2005WO2005105742A1 Processes for producing 1-benzyl-4-[(5,6-dimethoxy-1­indanon)-2-yl]methylpiperidine and hydrochloride thereof
11/10/2005WO2005105729A1 Polyamine analogs that activate antizyme frameshifting
11/10/2005WO2001009093A8 Benzenamine derivatives as anti-coagulants
11/10/2005US20050250944 Synthesis and uses of synephrine derivatives
11/10/2005US20050250819 Inhibitors of bacterial type III protein secretion systems
11/10/2005US20050250815 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
11/10/2005US20050250814 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/10/2005US20050250812 Methods for treating lewy body dementia
11/10/2005US20050250811 Such as 14-O-[4-hydroxy-N-valyl-piperidin-3-yl]-sulfanylacetylmutilin
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250789 Hydroxamic acid derivatives as metalloprotease inhibitors
11/10/2005US20050250781 (1-piperidine-3-cyclopentane)-amide derivatives; antiinflammatory agent, antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis
11/10/2005US20050250768 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
11/10/2005US20050250743 Ammonium salts of inositol hexaphosphate, and uses thereof
11/10/2005DE4317672B4 Homogene Schmelzmasse in Form einer festen Lösung aus Verbindungen mit sterisch gehinderten Aminogruppen, ein Verfahren zu deren Herstellung und deren Verwendung zum Stabilisieren von polymeren Natur- und Kunststoffen Homogeneous molten mass in the form of a solid solution of compounds with sterically hindered amino groups, a process for their preparation and their use for stabilizing polymeric natural products and plastics
11/10/2005DE102004019492A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005CA2555862A1 Polyamine analogs that activate antizyme frameshifting
11/10/2005CA2506407A1 Process for preparing 4-substituted 2,2,6,6-tetramethylpiperidin-n-oxy and 2,2,6,6-tetramethylpiperidin-n-hydroxy compounds
11/09/2005EP1593667A1 Amine derivative
11/09/2005EP1592685A1 BIPHENYL DERIVATIVES HAVING &bgr; sb 2 /sb ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
11/09/2005EP1592664A1 Graftable hindered amine light stabilizers
11/09/2005EP1592663A1 Method for the production of d-threo-2-phenyl-2-piperidine-2-yl acetates
1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 380